Third Harmonic Bio Inc (THRD) Stock Analyst Ratings
NASDAQ:THRD - US88427A1079 - Common Stock
5.38 USD
0 (-0.09%)
5.38 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 43% to THRD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.06. This target is -43.12% below the current price.
THRD was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about THRD.
In the previous month the buy percentage consensus was at a similar level.
THRD was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-28 | Stifel | Downgrade | Buy -> Hold |
| 2025-02-12 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-02-11 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2024-08-09 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2024-06-18 | Stifel | Initiate | Buy |
| 2024-06-07 | Raymond James | Initiate | Outperform |
| 2023-08-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2022-12-16 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2022-12-16 | Jefferies | Downgrade | Buy -> Hold |
| 2022-10-10 | Cowen & Co. | Initiate | Outperform |
| 2022-10-10 | Morgan Stanley | Initiate | Overweight |
| 2022-10-10 | Jefferies | Initiate | Buy |